The use of an implantable cardiac defibrillator (ICD) can provide a significant reduction in mortality in heart failure patients, according to a study coordinated by researchers from the Duke Clinical Research Institute.
"Treatment using conventional therapy plus an implantable cardiac defibrillator showed a statistically significant reduction in total mortality when compared to standard treatment with a placebo and standard treatment with amiodarone, an anti-arrhythmia drug," said Kerry L. Lee, Ph.D., an associate professor of biostatistics at Duke and principal investigator of the data coordinating center of the trial.
Results of the trial, called SCD-HeFT (Sudden Cardiac Death in Heart Failure Trial), were presented today (March 8, 2004) at the American College of Cardiology scientific sessions. The trial was sponsored by the National Heart, Lung and Blood Institute (NHLBI). Medtronic, Inc., Minneapolis, supplied the ICDs and Wyeth Pharmaceuticals, Madison, N.J., supplied the amiodarone and placebo pills. Lee has no financial interests in either company.
Richard Puff | dukemed news
Potential seen for tailoring treatment for acute myeloid leukemia
10.12.2018 | University of Washington Health Sciences/UW Medicine
UC San Diego researchers develop sensors to detect and measure cancer's ability to spread
06.12.2018 | University of California - San Diego
What if a sensor sensing a thing could be part of the thing itself? Rice University engineers believe they have a two-dimensional solution to do just that.
Rice engineers led by materials scientists Pulickel Ajayan and Jun Lou have developed a method to make atom-flat sensors that seamlessly integrate with devices...
Scientists at the University of Stuttgart and the Karlsruhe Institute of Technology (KIT) succeed in important further development on the way to quantum Computers.
Quantum computers one day should be able to solve certain computing problems much faster than a classical computer. One of the most promising approaches is...
New Project SNAPSTER: Novel luminescent materials by encapsulating phosphorescent metal clusters with organic liquid crystals
Nowadays energy conversion in lighting and optoelectronic devices requires the use of rare earth oxides.
Scientists have discovered the first synthetic material that becomes thicker - at the molecular level - as it is stretched.
Researchers led by Dr Devesh Mistry from the University of Leeds discovered a new non-porous material that has unique and inherent "auxetic" stretching...
Scientists from the Theory Department of the Max Planck Institute for the Structure and Dynamics of Matter (MPSD) at the Center for Free-Electron Laser Science (CFEL) in Hamburg have shown through theoretical calculations and computer simulations that the force between electrons and lattice distortions in an atomically thin two-dimensional superconductor can be controlled with virtual photons. This could aid the development of new superconductors for energy-saving devices and many other technical applications.
The vacuum is not empty. It may sound like magic to laypeople but it has occupied physicists since the birth of quantum mechanics.
10.12.2018 | Event News
06.12.2018 | Event News
03.12.2018 | Event News
10.12.2018 | Life Sciences
10.12.2018 | Physics and Astronomy
10.12.2018 | Life Sciences